Terlipressin Decreases Vascular Endothelial Growth Factor Expression and Improves Oxygenation in Patients with Acute Respiratory Distress Syndrome and Shock

BACKGROUND: Recent clinical data suggest that treatment with terlipressin (TP) may be more advantageous for septic shock than catecholamines. However, it is unknown whether TP would be effective for acute respiratory distress syndrome (ARDS) patients with shock. OBJECTIVES: The aim of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Feng, Wang, Xiang, Zhu, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2013
Materias:
Selected Topics: Critical Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904411/
https://www.ncbi.nlm.nih.gov/pubmed/22921855
http://dx.doi.org/10.1016/j.jemermed.2012.02.073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904411/
https://www.ncbi.nlm.nih.gov/pubmed/22921855
http://dx.doi.org/10.1016/j.jemermed.2012.02.073

Ejemplares similares